Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
46 Cards in this Set
- Front
- Back
Lowest potency FGAs?
|
chlorpromazine
thioridazine |
|
Highest potency FGAs?
|
fluphenazine
haloperidol pimozide |
|
Haloperidol:
half-life? metabolism? |
12 - 36 hrs
CYP 1A2, 2D6, 3A4 |
|
Phenothiazines:
half-life? metabolism? high/low protein binding? |
8 - 35 hrs
CYP 3A4, 2D6 HIGHLY protein bound |
|
Half-life of loxapine?
|
bi-phasic
initial 5 hrs terminal 12-19 hrs |
|
Half-life of thiothixene?
|
> 24 hrs (w/ chronic use)
|
|
Low potency FGA AEs:
sedative effects? high/low ACh effects? high/low EPS? high/low Hypotensive effects? high/low |
Low potency FGA AEs:
sedative effects? high ACh effects? high EPS? low Hypotensive effects? high/ |
|
High potency FGA AEs:
sedative effects? high/low ACh effects? high/low EPS? high/low Hypotensive effects? high/low |
High potency FGA AEs:
sedative effects? low ACh effects? low EPS? high! Hypotensive effects? low |
|
Movement disorder:
bizarre involuntary tonic contractions of skeletal muscles (mostly head & face) |
acute dystonic reaction: bizarre involuntary tonic contractions of skeletal muscles (mostly head & face)
|
|
Movement Disorders:
strong feeling of inner restlessness |
akathisia: strong feeling of inner restlessness
|
|
Movement Disorder rating scales: SAS
What does it stand for? What does it rate? |
SAS (Simpson-Angus Scale)
Parkinsonism |
|
Movement Disorder Rating Scales:
Tardive dyskinesia? |
AIMS (abnormal involuntary movement scale)
& DISCUS (dyskinesia identification system: condensed user scale) |
|
Movement Disorder Rating Scales: BARS
Stands for what? Rates what? |
BARS (Barnes Akathisia Rating Scale)
Akathisia |
|
LAI Dosing: Fluphenazine
Starting Dose? Target Dose? Max Dose? Dose interval? PO overlap? |
LAI Dosing: Fluphenazine
Starting Dose? 12.5 - 25 mg Target Dose? 12.5 - 50 mg Max Dose? 100mg/dose Dose interval? q 2-4 wks PO overlap? recommmended |
|
LAI Dosing: Haloperidol
Starting Dose? Target Dose? Max Dose? Dose interval? PO overlap? |
LAI Dosing: Haloperidol
Starting Dose? 10-20x daily PO dose Target Dose? 10-15x daily po dose Max Dose? 100mg 1st dose; 450mg/mo Dose interval? q 4 wks PO overlap? recommended |
|
LAI Dosing: Risperidone
Starting Dose? Target Dose? Max Dose? Dose interval? PO overlap? |
LAI Dosing: Risperidone
Starting Dose? 25 mg + PO dose x 3 wks Target Dose? 25-50 mg Max Dose? 50mg Dose interval? q 2 wks PO overlap? required |
|
LAI Dosing: Paliperidone
Starting Dose? Target Dose? Max Dose? Dose interval? PO overlap? |
LAI Dosing: Paliperidone
Starting Dose? 234 mg then 156 mg day 8 Target Dose? 117 mg (39-234 mg) Max Dose? 234 mg Dose interval? q 4 wks PO overlap? not required |
|
LAI Dosing: Olanzapine
Starting Dose? Target Dose? Max Dose? Dose interval? PO overlap? |
LAI Dosing: Olanzapine
Starting Dose? 150-300mg q2w or 405 q4w Target Dose? 150-300mg q2w or 405 q4w Max Dose? 300mg q2w or 405mg q4w Dose interval? q 2 wks or q 4 wks PO overlap? not required |
|
Brand Name for Paliperidone?
|
Invega
|
|
Brand Name for Olanzapine?
|
Zyprexa
|
|
Brand Name for Ziprasidone?
|
Geodon
|
|
Brand Name for Quetiapine?
|
Seroquel
|
|
Brand Name for Aripriprazole?
|
Abilify
|
|
SGA Dosing: Clozapine (Clozaril)
Dose Range? |
300-450 mg/day
|
|
SGA Dosing: Risperidone (Risperdal)
Dose Range? |
2-6 mg/day
|
|
SGA Dosing: Olanzapine (Zyprexa)
Dose Range? |
5-20 mg/day
|
|
SGA Dosing: Quetiapine (Seroquel)
Dose Range? |
300-800 mg/day
|
|
SGA Dosing: Ziprasidone (Geodon)
Dose Range? |
120-160 mg/day
|
|
SGA Dosing: Aripiprazole (Abilify)
Dose Range? |
10-15 mg/day
|
|
SGA Dosing: Palparidone (Invega)
Dose Range? |
6-12 mg/day
|
|
SGA Dosing: Iloperidone (Fanapt)
Dose Range? |
12-24 mg/day
|
|
SGA Dosing: Asenapine (Saphris)
Dose Range? |
5 mg BID
|
|
SGA AEs:
highest risk for dose related EPS? & increased prolactin? (2 drugs) |
Risperidone
Paliperidone |
|
SGA AEs:
Drug most likely to cause 1) dose dependent lowering of seizure threshold 2) orthostatic hypotension |
clozapine
|
|
SGA AEs:
3 drugs most likely to cause sedation? |
clozapine (Clozaril)
quetiapine (Seroquel) olanzapine (Zyprexa) |
|
SGA AEs:
2 drugs most likely to cause weight gain? |
clozapine (Clozaril)
olanzapine (Zyprexa) |
|
SGA AEs:
3 drugs most likely to cause 1) lipid abnormalities 2) glucose intolerance |
clozapine (Clozaril)
olanzapine (Zyprexa) quetiapine (Seroquel) |
|
ADA montoring recommendations for the use of antipsychotics & DM
Blood pressure & Fasting glucose should be measured when? |
baseline, 12 wks, then annually
|
|
ADA montoring recommendations for the use of antipsychotics & DM
Fasting lipids should be measured when? |
baseline, 12 wks, then q 5 yrs
|
|
ADA montoring recommendations for the use of antipsychotics & DM
Waste circumference should be measured when? |
baseline, then annually
|
|
ADA montoring recommendations for the use of antipsychotics & DM
Weight (BMI) should be measured when? |
baseline, 4 wks, 8 wks, 12 wks, quarterly, & annually
|
|
SGA metabolism
clozapine & olanzapine? |
1A2 (major)
|
|
SGA metabolism:
Risperidone & Aripiprazole? |
2D6 (major)
|
|
SGA metabolism:
Quetiapine (Seroquel)? |
3A4 (major)
|
|
SGA metabolism:
Ziprasidone? |
2/3 aldehyde oxidase
1/3 3A4 |
|
Clozapine montoring:
every ___ for ___ then every ___ for ___ then every ___ |
every week for 6 mo
then every 2 weeks for 6 mo then every 4 wks |